Cormorant Asset Management LP 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:04 pm Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Cormorant Asset Management LP | 0 0.000% | -3,250,000 (Position Closed) | Filing |
| 2024-02-14 3:07 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Cormorant Asset Management LP | 3,250,000 5.960% | 450,000 (+16.07%) | Filing |
| 2023-10-10 4:01 pm Purchase | 2023-09-29 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Cormorant Asset Management LP | 2,800,000 5.530% | 2,800,000 (New Position) | Filing |